Antidepressant-like properties of sarizotan in experimental Parkinsonism

Psychopharmacology

Volumn 218, Issue 4, 2011, Pages 621-634

  Zhang, Xiaoqun ^a   Egeland, Martin ^a   Svenningsson, Per ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

6 hydroxydopamine; Bromodeoxyuridine; Doublecortin; Ki 67; Modified forced swim test; Parkinson's disease; Serotonin

Indexed keywords

BENSERAZIDE PLUS LEVODOPA; BROXURIDINE; DOUBLECORTIN; KI 67 ANTIGEN; OXIDOPAMINE; SARIZOTAN;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; CELL PROLIFERATION; CIRCLING BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; DENTATE GYRUS; DEPRESSION; DRUG DOSE COMPARISON; DYSKINESIA; FORCED SWIMMING TEST; HISTOLOGY; HISTOPATHOLOGY; HYPOPHYSIS; IMMOBILIZATION; LOCOMOTION; MALE; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; RAT; SENSITIZATION; SUBGRANULAR ZONE; SUBVENTRICULAR ZONE;

ANIMALS; ANTIDEPRESSIVE AGENTS; ANTIPARKINSON AGENTS; BEHAVIOR, ANIMAL; BENSERAZIDE; CELL PROLIFERATION; DENTATE GYRUS; DEPRESSION; DISEASE MODELS, ANIMAL; DRUG COMBINATIONS; LEVODOPA; LOCOMOTION; MALE; ORGANIC CHEMICALS; PARKINSONIAN DISORDERS; RATS; RATS, SPRAGUE-DAWLEY; SWIMMING;

EID: 82955249032     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2356-7     Document Type: Article

References (26)

1. M Banasr M Hery R Printemps A Daszuta 2004 Serotonin-induced increases in adult cell proliferation and neurogenesis are mediated through different and common 5-HT receptor subtypes in the dentate gyrus and the subventricular zone Neuropsychopharmacology 29 450 460 14872203 10.1038/sj.npp.1300320 1:CAS:528:DC%2BD2cXhtlWksbw%3D (Pubitemid 38365922)
2. W Bara-Jimenez F Bibbiani MJ Morris T Dimitrova A Sherzai MM Mouradian TN Chase 2005 Effects of serotonin 5-HT1A agonist in advanced Parkinson's disease Mov Disord 20 932 936 15791634 10.1002/mds.20370 (Pubitemid 41419506)
3. GD Bartoszyk C Van Amsterdam HE Greiner W Rautenberg H Russ CA Seyfried 2004 Sarizotan, a serotonin 5-HT1A receptor agonist and dopamine receptor ligand. 1. Neurochemical profile J Neural Transm 111 113 126 14767715 10.1007/s00702-003-0094-7 1:CAS:528:DC%2BD2cXhtVOlsLw%3D (Pubitemid 38283223)
4. F Bibbiani JD Oh TN Chase 2001 Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian models Neurology 57 1829 1834 11723272 1:CAS:528:DC%2BD38XjvVI%3D (Pubitemid 33096691)
5. LA Bruins Slot L Bardin AL Auclair R Depoortere A Newman-Tancredi 2008 Effects of antipsychotics and reference monoaminergic ligands on marble burying behavior in mice Behav Pharmacol 19 145 152 18332679 10.1097/FBP. 0b013e3282f62cb2 1:CAS:528:DC%2BD1cXjtVektLg%3D (Pubitemid 351365692)
6. KR Chaudhuri DG Healy AH Schapira 2006 Non-motor symptoms of Parkinson's disease: diagnosis and management Lancet Neurol 5 235 245 16488379 10.1016/S1474-4422(06)70373-8 (Pubitemid 43238347)
7. E Ericson J Samuelsson S Ahlenius 1991 Photocell measurements of rat motor activity. A contribution to sensitivity and variation in behavioral observations J Pharmacol Methods 25 111 122 2067382 10.1016/0160-5402(91)90002-M 1:CAS:528:DyaK3MXktVSisrY%3D
8. Gerlach M, Bartoszyk GD, Riederer P, Dean O, van den Buuse M (2011) Role of dopamine D(3) and serotonin 5-HT (1A) receptors in l-DOPA-induced dyskinesias and effects of sarizotan in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease. J Neural Transm. PMID:21253782
9. CG Goetz P Damier C Hicking E Laska T Muller CW Olanow O Rascol H Russ 2007 Sarizotan as a treatment for dyskinesias in Parkinson's disease: a double-blind placebo-controlled trial Mov Disord 22 179 186 17094088 10.1002/mds.21226 (Pubitemid 46374758)
10. GU Hoglinger P Rizk MP Muriel C Duyckaerts WH Oertel I Caille EC Hirsch 2004 Dopamine depletion impairs precursor cell proliferation in Parkinson's disease Nat Neurosci 7 726 735 15195095 10.1038/nn1265 (Pubitemid 38859057)
11. TE Kippin S Kapur D van der Kooy 2005 Dopamine specifically inhibits forebrain neural stem cell proliferation, suggesting a novel effect of antipsychotic drugs J Neurosci 25 5815 5823 15958748 10.1523/JNEUROSCI.1120-05. 2005 1:CAS:528:DC%2BD2MXlsFent7c%3D (Pubitemid 40847894)
12. I Lucki 1997 The forced swimming test as a model for core and component behavioral effects of antidepressant drugs Behav Pharmacol 8 523 532 9832966 10.1097/00008877-199711000-00010 1:CAS:528:DyaK2sXnvFGju7Y%3D (Pubitemid 27504702)
13. M Lundblad B Picconi H Lindgren MA Cenci 2004 A model of l-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function Neurobiol Dis 16 110 123 15207268 10.1016/j.nbd.2004.01.007 1:CAS:528:DC%2BD2cXjs1altbw%3D (Pubitemid 38569802)
14. JE Malberg AJ Eisch EJ Nestler RS Duman 2000 Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus J Neurosci 20 9104 9110 11124987 1:CAS:528:DC%2BD3MXis1SqsA%3D%3D (Pubitemid 32042912)
15. SS Newton RS Duman 2007 Neurogenic actions of atypical antipsychotic drugs and therapeutic implications CNS Drugs 21 715 725 17696572 10.2165/00023210-200721090-00002 1:CAS:528:DC%2BD2sXhtFars7rN (Pubitemid 47294718)
16. S Pålhagen H Qi B Mårtensson J Wålinder AK Granérus P Svenningsson 2010 Monoamines, BDNF, IL-6 and corticosterone in CSF in patients with Parkinson's disease and major depression J Neurol 257 524 532 19844754 10.1007/s00415-009-5353-6
17. RD Porsolt M Le Pichon M Jalfre 1977 Depression: a new animal model sensitive to antidepressant treatments Nature 266 730 732 559941 10.1038/266730a0 1:CAS:528:DyaE2sXkvFGhur4%3D (Pubitemid 8073804)
18. JJ Radley BL Jacobs 2002 5-HT1A receptor antagonist administration decreases cell proliferation in the dentate gyrus Brain Res 955 264 267 12419546 10.1016/S0006-8993(02)03477-7 1:CAS:528:DC%2BD38Xotl2iur8%3D (Pubitemid 35284859)
19. S Ramboz R Oosting DA Amara HF Kung P Blier M Mendelsohn JJ Mann D Brunner R Hen 1998 Serotonin receptor 1A knockout: an animal model of anxiety-related disorder Proc Natl Acad Sci USA 95 14476 14481 9826725 10.1073/pnas.95.24.14476 1:CAS:528:DyaK1cXns1Glsbs%3D (Pubitemid 28549392)
20. JS Reijnders U Ehrt WE Weber D Aarsland AF Leentjens 2008 A systematic review of prevalence studies of depression in Parkinson's disease Mov Disord 23 183 189 17987654 10.1002/mds.21803 quiz 313 (Pubitemid 351311545)
21. A Sahay R Hen 2007 Adult hippocampal neurogenesis in depression Nat Neurosci 10 1110 1115 17726477 10.1038/nn1969 1:CAS:528:DC%2BD2sXps1Sgu7s%3D (Pubitemid 47339960)
22. L Santarelli M Saxe C Gross A Surget F Battaglia S Dulawa N Weisstaub J Lee R Duman O Arancio C Belzung R Hen 2003 Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants Science 301 805 809 12907793 10.1126/science.1083328 1:CAS:528:DC%2BD3sXmtVGqsrY%3D (Pubitemid 36962615)
23. J Savitz I Lucki WC Drevets 2009 5-HT(1A) receptor function in major depressive disorder Prog Neurobiol 88 17 31 19428959 10.1016/j.pneurobio.2009. 01.009 1:CAS:528:DC%2BD1MXltFWiurg%3D
24. T Scholzen J Gerdes 2000 The Ki-67 protein: from the known and the unknown J Cell Physiol 182 311 322 10653597 10.1002/(SICI)1097-4652(200003)182: 3<311::AID-JCP1>3.0.CO;2-9 1:CAS:528:DC%2BD3cXot1Ggsg%3D%3D (Pubitemid 30054364)
25. P Yang SA Arnold A Habas M Hetman T Hagg 2008 Ciliary neurotrophic factor mediates dopamine D2 receptor-induced CNS neurogenesis in adult mice J Neurosci 28 2231 2241 18305256 10.1523/JNEUROSCI.3574-07.2008 1:CAS:528: DC%2BD1cXjt1Cqu7c%3D (Pubitemid 351317623)
26. X Zhang PE Andren P Greengard P Svenningsson 2008 Evidence for a role of the 5-HT1B receptor and its adaptor protein, p11, in l-DOPA treatment of an animal model of Parkinsonism Proc Natl Acad Sci USA 105 2163 2168 18256188 10.1073/pnas.0711839105 1:CAS:528:DC%2BD1cXisVWmsbY%3D (Pubitemid 351439482)